Drug Regulatory Information | Announcement of the National Medical Products Administration on the Issuance of Work Procedures for the Review and Approval of Conditional Marketing Applications for Drug
2026/04/27
Attachment 1: Work Procedure for Review and Approval of Conditional Approval Application for Drug Marketing
Attachment 2: Policy Interpretation
- Pre：Frontier Technology Exploration | Shandong Xinbo Pharmaceutical R&D Co., Ltd. held a seminar on organoid and organ chip technology
- Next：Drug Regulatory Information | Notice on Publicly Soliciting Opinions on the "Technical Guidelines for Pharmaceutical Research and Evaluation of Mesenchymal Stem Cell Products (Draft for Comments)"
